Challenges Therapists Face Amid Coronavirus Scare
From the public market in Wuhan, China, the coronavirus has reached the soils of Canada. There is still uncertainty about when the disease will...
Study finds structural brain alterations in patients with irritable bowel syndrome
A large academic study has demonstrated structural changes in specific brain regions in female patients with irritable bowel syndrome (IBS), a condition that...
Queen’s University leading clinical trial on cell therapy treatment for COVID19 patients
Researchers at Queen’s University Belfast are leading a UK-wide clinical trial, offering an innovative cell therapy treatment for COVID-19 patients with acute respiratory failure.This...
Oxford University Imaging Lab and Zegami comes together to target Cardiovascular disease
Zegami, the data visualisation company, has been appointed by Oxford University researchers at the Oxford Cardiovascular Clinical Research Facility to accelerate research into cardiovascular...
Research Spotlight: A Two-Part Priming Strategy to Increase the Sensitivity of Liquid Biopsies
What Question Were You Investigating with this Study?Liquid biopsies, such as blood draws, can allow for the noninvasive diagnosis and monitoring of disease. The...
Preliminary Clinical Trial Results Show ‘Dramatic and Rapid Regression’ of Glioblastoma after Next Generation...
A collaborative project to bring the promise of cell therapy to patients with a deadly form of brain cancer has shown dramatic results among...
New Brigham Research Highlights Combining Prostate MRI with a Blood Test to Avoid Unnecessary...
A new meta-analysis by investigators from Brigham and Women’s Hospital, a founding member of the Mass General Brigham healthcare system, suggests that doctors and...
Generative AI Practitioners in Healthcare Prioritize Industry-Specific and Task-Specific Models as Budgets Surge 300%,...
John Snow Labs, the AI for healthcare company announced the findings of the inaugural Generative AI in Healthcare Survey. Conducted by Gradient Flow, the...
MRM Health Reports Safety and Positive Efficacy Data in Pouchitis in Phase 2a Clinical...
MRM Health NV, a clinical-stage biopharmaceutical company developing innovative therapeutics for inflammatory, CNS and metabolic diseases, today reports positive topline results from its Phase...
